MARTINELLI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 404
EU - Europa 235
AS - Asia 109
AF - Africa 1
Totale 749
Nazione #
US - Stati Uniti d'America 403
IE - Irlanda 169
CN - Cina 89
FI - Finlandia 26
IT - Italia 16
DE - Germania 15
SG - Singapore 15
BE - Belgio 2
GB - Regno Unito 2
IN - India 2
JP - Giappone 2
UA - Ucraina 2
AT - Austria 1
CA - Canada 1
CZ - Repubblica Ceca 1
NL - Olanda 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 749
Città #
Dublin 169
Chandler 128
Ashburn 32
Helsinki 26
Lawrence 21
Princeton 21
Medford 20
Nanjing 20
New York 19
Shanghai 18
Boardman 11
Shenyang 10
Beijing 9
Nanchang 9
Wilmington 9
Singapore 8
Los Angeles 7
Changsha 6
Cagliari 4
Chicago 4
Hebei 4
Norwalk 4
Pavia 4
Jiaxing 3
Redwood City 3
Seattle 3
Tianjin 3
Washington 3
Woodbridge 3
Anzio 2
Brussels 2
Fairfield 2
Guangzhou 2
Hangzhou 2
Jacksonville 2
Tokyo 2
Amsterdam 1
Ann Arbor 1
Atlanta 1
Bangkok 1
Brescia 1
Brno 1
Centurion 1
Como 1
Germantown 1
Houston 1
Kurnool 1
London 1
Munich 1
Portland 1
Pune 1
Rome 1
Shenzhen 1
South Shields 1
Taizhou 1
Toronto 1
Vienna 1
Totale 616
Nome #
Botulinum toxin for chronic migraine: Clinical trials and technical aspects 53
Frontal and cerebellar atrophy supports FTSD-ALS clinical continuum 46
A machine learning approach for the differential diagnosis of Alzheimer and vascular dementia fed by MRI selected features. 42
The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait 42
BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm 42
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: Additional findings from the randomized, sham-controlled, double-blind PRESTO trial 11 Medical and Health Sciences 1103 Clinical Sciences 40
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: A post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 39
Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults 36
Neurophysiological and biomolecular effects of erenumab in chronic migraine: An open label study 36
Anodal transcranial direct current stimulation in chronic migraine and medication overuse headache: A pilot double-blind randomized sham-controlled trial 36
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study 36
Peripheral vagal nerve stimulation modulates the nociceptive withdrawal reflex in healthy subjects: A randomized, cross-over, sham-controlled study 35
Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study 31
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults 31
Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation 31
Correction to: Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study (The Journal of Headache and Pain, (2021), 22, 1, (114), 10.1186/s10194-021-01333-4) 31
Migraine neuroscience: from experimental models to target therapy 28
Chronic migraine and Botulinum Toxin Type A: Where do paths cross? 26
Lasmiditan: an additional therapeutic option for the acute treatment of migraine 25
Functional and structural MRI signature of the induced migraine attack 24
Thalamocortical connectivity in experimentally-induced migraine attacks: A pilot study 22
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial 21
Guidelines of the International Headache Society for clinical trials with neuromodulation devices for the treatment of migraine 20
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 6
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 2
Totale 781
Categoria #
all - tutte 4.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.079


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202070 24 35 0 0 0 0 0 0 1 0 6 4
2020/202129 2 0 0 3 1 11 1 8 2 1 0 0
2021/202271 0 1 1 0 0 0 0 10 3 0 9 47
2022/2023375 36 36 1 32 28 28 1 14 180 6 11 2
2023/2024199 34 20 8 17 19 38 4 20 4 10 6 19
2024/202520 20 0 0 0 0 0 0 0 0 0 0 0
Totale 781